Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors

University of Manchester 2020. Cyclic diarylboron derivatives as NLRP3 inflammasome inhibitors. US 10570157. [Patent].

PDF - Published Version
Download (4MB) | Preview


Inhibitor compounds are disclosed. The compounds are effective in the treatment of diseases or conditions in which interleukin 1 .beta. activity is implicated. Methods of synthesis of the compounds, as well as pharmaceutical compositions comprising the compounds are also disclosed.

Item Type: Patent
Date Type: Published Online
Status: Published
Schools: Biosciences
Publisher: US Patent
Date of First Compliant Deposit: 18 May 2020
Date of Acceptance: 25 February 2020
Last Modified: 19 May 2020 15:03

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics